| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/23/2012 | US20120046422 Multi-Arm Block Copolymers as Drug Delivery Vehicles |
| 02/23/2012 | US20120046349 Compositions for targeting conducting airway cells comprising adeno-associated virus constructs |
| 02/23/2012 | US20120046281 Rifalazil compositions and therapeutic regimens |
| 02/23/2012 | US20120046252 Calcium Formate for Use as a Dietary Supplement |
| 02/23/2012 | US20120046240 Method of Producing Hydroxyalkyl Starch Derivatives |
| 02/23/2012 | US20120046235 Conjugates of hydroxyalkyl starch and a protein, prepared by native chemical ligation |
| 02/23/2012 | US20120045513 Polymer-based, sustained release drug delivery system |
| 02/23/2012 | US20120045495 Higher loading zinc-containing films |
| 02/23/2012 | US20120045494 Gum Base |
| 02/23/2012 | US20120045487 Multiphasic microfibers for spatially guided cell growth |
| 02/23/2012 | US20120045486 Delivery systems |
| 02/23/2012 | US20120045484 Calcium phosphate/sulfate-based bone implant composition |
| 02/23/2012 | US20120045479 Dry Powder Formulations, Vaccines and Methods |
| 02/23/2012 | US20120045456 Stabilized anti-respiratory syncytial virus (rsv) antibody formulations |
| 02/23/2012 | US20120045432 B lymphocyte stimulator assays |
| 02/23/2012 | US20120045396 Porous structures with modified biodegradation kinetics |
| 02/23/2012 | CA2846000A1 Engineering multifunctional and multivalent molecules with collagen xv trimerization domain |
| 02/23/2012 | CA2844292A1 Devices and methods for intravaginal delivery of drugs and other substances |
| 02/23/2012 | CA2808907A1 Therapeutic peptide-polymer conjugates, particles, compositions, and related methods |
| 02/23/2012 | CA2808901A1 Conjugates, particles, compositions, and related methods |
| 02/23/2012 | CA2808628A1 Ophthalmic formulations of squalamine |
| 02/23/2012 | CA2808624A1 Lipidated immune response modifier compound compositions, formulations, and methods |
| 02/23/2012 | CA2808622A1 Method of stabilizing and sterilizing peptides or proteins |
| 02/23/2012 | CA2808596A1 Modified relaxin polypeptides and their uses |
| 02/23/2012 | CA2808276A1 Intravaginal devices, methods of making, and uses thereof |
| 02/23/2012 | CA2808211A1 Combination therapy with anti-cd74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases |
| 02/23/2012 | CA2808210A1 Composition comprising tetracyclic compound |
| 02/23/2012 | CA2808207A1 A novel method for creating, suspending and stabilizing electronically modified reaction intermedeates |
| 02/23/2012 | CA2808019A1 Particulate substances comprising ceramic particles for delivery of biomolecules |
| 02/23/2012 | CA2806616A1 Oligonucleotide chelate complexes |
| 02/23/2012 | CA2804333A1 Nalbuphine-based formulations and uses thereof |
| 02/22/2012 | EP2420517A1 Polysaccharide derivative and hydrogel thereof |
| 02/22/2012 | EP2420255A2 Polypeptide inhibitors of urokinase type plasminogen activator |
| 02/22/2012 | EP2420254A1 Method for producing conjugate of thyroxine and albumin |
| 02/22/2012 | EP2420253A1 Engineering multifunctional and multivalent molecules with collagen XV trimerization domain |
| 02/22/2012 | EP2420247A1 Adenovirus formulations |
| 02/22/2012 | EP2420241A1 Transdermal delivery of beneficial substances effected by a hostile biophysical environment |
| 02/22/2012 | EP2420223A1 Aqueous pharmaceutical compositions containing borate-polyol complexes |
| 02/22/2012 | EP2419535A1 Delivery of oligonucleotide-functionalized nanoparticles |
| 02/22/2012 | EP2419452A1 Affinity material |
| 02/22/2012 | EP2419451A1 Antibodies against prostate specific membrane antigen |
| 02/22/2012 | EP2419437A1 Peptides used in the treatment and/or care of the skin and/or hair and their use in cosmetic or pharmaceutical compositions |
| 02/22/2012 | EP2419176A1 Pharmaceutical composition comprising glycerol, white soft paraffin and liquid paraffin for the treatment of uremic xerosis and/or pruritus |
| 02/22/2012 | EP2419143A1 Hpv particles and uses thereof |
| 02/22/2012 | EP2419142A2 Pretargeting kit, method and agents used therein |
| 02/22/2012 | EP2419141A1 Pretargeting kit, method and agents used therein |
| 02/22/2012 | EP2419140A2 Diazeniumdiolated phosphorylcholine polymers for nitric oxide release |
| 02/22/2012 | EP2419139A2 Polymeric drug delivery systems and processes for producing such systems |
| 02/22/2012 | EP2419138A1 Gel compositions for administration of pharmaceutically active compounds |
| 02/22/2012 | EP2419102A1 Methods for inhibiting angiogenesis with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
| 02/22/2012 | EP2419098A2 A medicinal cream made using miconazole nitrate and chitosan, and a process to make the same |
| 02/22/2012 | EP2419092A2 Pharmaceutical composition for treating dermatological autoimmune diseases |
| 02/22/2012 | EP2419090A1 Bioavailable capsule compositions of amorphous alpha-(n-sulfonamido)acetamide compound |
| 02/22/2012 | EP2419089A1 Formulation for stabilizing proteins, which is free of mammalian excipients |
| 02/22/2012 | EP2419087A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it |
| 02/22/2012 | EP2419084A2 A medicinal cream made using clotrimazole and chitosan and a process to make the same |
| 02/22/2012 | EP2419083A2 A medicinal cream made using silver sulphadiazine and chitosan and a process to make it |
| 02/22/2012 | EP2361988A9 Molecular marker for cancer stem cell |
| 02/22/2012 | EP1926757B1 Antibody-comb polymer conjugate |
| 02/22/2012 | EP1890706B1 Process for the preparation and isolation of phosphatides |
| 02/22/2012 | EP1799268B1 Magnetic particles for therapy and diagnosis |
| 02/22/2012 | EP1740608B1 Modified human growth hormone polypeptides and their uses |
| 02/22/2012 | EP1708752B1 Polymer-bound antibody cancer therapeutic agent |
| 02/22/2012 | EP1652517B1 Hyaluronic acid nanoparticles |
| 02/22/2012 | EP1648496B1 Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatment |
| 02/22/2012 | EP1575531B9 Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta |
| 02/22/2012 | EP1558226B1 Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics |
| 02/22/2012 | EP1524975B9 Improved transdermal delivery system for the administration of rotigotine |
| 02/22/2012 | EP1509231B1 System for peritoneal dialysis comprising a reservoir of dialysis solution and a cartridge containing taurolidine powder |
| 02/22/2012 | EP1104287B1 Method for the preparation of oxide microcapsules loaded with functional molecules and the products obtained thereof |
| 02/22/2012 | CN202146448U 具有降血糖、血脂功效的茶色素胶囊 Tea pigment capsule has a hypoglycemic, lipid efficacy |
| 02/22/2012 | CN1980695B 抗原递送载体和构建物 Antigen delivery vectors and constructs |
| 02/22/2012 | CN1789341B 用于对塑料和建筑材料着色的、色强度高的、还原和氧化稳定的铁黑颜料 Used for coloring plastics and building materials, high color strength, reduction and oxidation stability of iron black pigment |
| 02/22/2012 | CN1688702B 表达rna病毒抗原表位的重组麻疹病毒在制备疫苗组合物中的用途 Expression rna viral epitopes in the preparation of a recombinant measles virus vaccine composition of use |
| 02/22/2012 | CN102361951A Base material for spraying comprising low-molecular gelling agent |
| 02/22/2012 | CN102361652A Adhesion preventing composition, solid preparation and method for producing same |
| 02/22/2012 | CN102361651A Stable iron oligosaccharide compound |
| 02/22/2012 | CN102361650A Novel lipids and compositions for the delivery of therapeutics |
| 02/22/2012 | CN102361647A Fgf21 derivatives with albumin binder a-b-c-d-e- and their use |
| 02/22/2012 | CN102361639A Adhesive patch-containing package bag and method for storing adhesive patch |
| 02/22/2012 | CN102361638A Transdermal preparation |
| 02/22/2012 | CN102361636A Amino acid-conjugated cyanoacrylate polymer particles |
| 02/22/2012 | CN102361635A Coated solid preparation |
| 02/22/2012 | CN102361633A Pharmaceutical composition comprising aliskiren |
| 02/22/2012 | CN102361630A Method for preparing suspensions of low-solubility materials |
| 02/22/2012 | CN102357250A Magnetic resonance imaging (MRI)-oriented high intensity focused ultrasound (HIFU) synergist and preparation method thereof |
| 02/22/2012 | CN102357242A Recombination cattle alkaline fibroblast growth factor gel |
| 02/22/2012 | CN102357235A Pasty pharmaceutical composition and preparation method thereof |
| 02/22/2012 | CN102357224A Aromatic pain-alleviating plaster |
| 02/22/2012 | CN102357215A Ointment for treating right hypochondriac distention and pain caused by acute and chronic cholecystitis |
| 02/22/2012 | CN102357184A Traditional Chinese medicine preparation for treating cough and preparation method thereof |
| 02/22/2012 | CN102357182A Traditional Chinese medicament for curing cough and preparation method thereof |
| 02/22/2012 | CN102357122A Masking type Chailian oral liquid and preparation method thereof |
| 02/22/2012 | CN102357099A Pharmaceutical composition with ornidazole |
| 02/22/2012 | CN102357098A Pharmaceutical composition, uses and preparing method thereof |
| 02/22/2012 | CN102357095A Stable medicinal composition |
| 02/22/2012 | CN102357093A Medicinal composition of methanesulfonic acid arbidol oral solid preparation |
| 02/22/2012 | CN102357091A Chlocibutamine slow release pharmaceutical composition |
| 02/22/2012 | CN102357090A Method for improving moisture resistance of Chinese medicinal hard capsules |
| 02/22/2012 | CN102357089A Pearlescent type film coating and preparation method thereof |